Browse treatments

…y of 0.73 (95% CI: 0.67 to 0.79) at the threshold of 150 ng/mL. DCA revealed a potential net benefit of pleural CCL22 determination…

…We read with great interest the article by Coté et al titled ‘Sphincterotomy for biliary sphincter of Oddi disorder and idiopathic acute rec…

…rapulmonary infection (18.3%). Only 38 patients (5.6%) received invasive mechanical ventilation. All-cause mortality 28 days after hospitalisation was 37.9% an…

…rs. Studies that used techniques to modulate immune cells (like Chimeric Antigen Receptor T cell therapy or peptide-based vaccines) were excluded. Studies should state …

…eatment as usual (TAU) or to a waitlist control group receiving TAU. Assessments will be conducted blind to group allocation at bas…

…ed, more recently in the form of single inhaler triple therapy (SITT).1–3 There are numerous established adverse effects of ICS (pne…

…ation (https://www.bmj.com/rapid-recommendations) on the use of antidiabetic treatments in people with type 2 diabetes mellitus.Results The systematic …

…promising avenue of scientific investigation—the development of mRNA vaccines—is threatened by current US funding decisions.…

…rly elevated in BAV and TAV patients with concurrent severe AS. AVR results in reduction in these parameters, but this was only sig…

…ging evidence of the condition, and only 12% ultimately receive treatment for IE. This has significant resource implications for an alrea…

… improved outcomes in patients with myocarditis, independent of GDMT. However, older patients and those not undergoing CMR received …

…ansformed the treatment of paroxysmal atrial fibrillation, with pulmonary vein isolation (PVI) being a key treatment. Technical advancements, including …